ÂÜÀòÂÒÂ×

Andy Rittenberg is an accomplished legal professional currently serving as the Executive Vice President and General Counsel at Coherus BioSciences since February 2024, where responsibilities include managing legal functions and providing strategic legal guidance to senior management and the Board of Directors across various areas. Prior experience includes Senior Vice President Legal and Chief Compliance Officer at Gilead Sciences, where contributions included supporting commercial launches of pharmaceutical products and navigating complex investigations, as well as overseeing compliance initiatives. Earlier roles include Associate Attorney at Covington & Burling, focusing on defending pharmaceutical companies in litigation, and serving as an Assistant in the Clinton Gore Administration, contributing to economic and healthcare policy. Andy Rittenberg holds a JD from the University of Chicago Law School and a BA from Yale University.